This stock has a huge potential and the chart has demonstrated that for the last 6 months. This recent activity bodes well for news about there Aristotle testing application for Cancer. From the market action, we should expect a doubling of the price in the near term. IF the news is good enough this may be a long term hold.
Commento:
I sold the stock when the price stropped moving higher at 1.21 it was double and I moved to side line.
The stock is now in buy zone but I have not pulled the trigger yet.
The stock is now in buy zone but I have not pulled the trigger yet.
Commento:
the low has been reached and buy around 68 for a move to 1.50
I will continue to hold and expect to hear good news in the coming weeks.
They market there Aristotle test soon and I expect to hbear it is a winner.